The expression of TRAP220 was increased in the livers of NASH patients and mice and was positively correlated with transforming growth factor ß (TGF-ß) signaling and profibrotic factors [54]. This evidence concerns the gene MED1 and metabolic dysfunction-associated steatohepatitis.